Andreas Nechansky

Andreas Nechansky is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as CEO and Qualified Person at VelaLabs GmbH since July 2023. Previously, Nechansky held several significant roles, including Managing Director and Site Manager for ABF Pharmaceutical Services, where responsibilities encompassed GMP warehousing, packaging, and quality services. Nechansky also contributed as VP of Research and Analytical Operations at Eden Biologics, focusing on biosimilar development and assay methodologies. Prior experience includes founding and leading operations at VelaLabs GmbH, emphasizing GMP compliance and analytical services. Nechansky's career began with research roles at Igeneon GmbH, The Scripps Research Institute, and Novartis, with a strong foundation in molecular genetics from the University of Vienna, complemented by a postgraduate study in pharmaceutical quality management.